117 related articles for article (PubMed ID: 9748277)
1. A conserved element in the serine protease domain of complement factor B.
Hourcade DE; Mitchell LM; Oglesby TJ
J Biol Chem; 1998 Oct; 273(40):25996-6000. PubMed ID: 9748277
[TBL] [Abstract][Full Text] [Related]
2. Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor B.
Hinshelwood J; Spencer DI; Edwards YJ; Perkins SJ
J Mol Biol; 1999 Nov; 294(2):587-99. PubMed ID: 10610782
[TBL] [Abstract][Full Text] [Related]
3. Human complement proteins D, C2, and B. Active site mapping with peptide thioester substrates.
Kam CM; McRae BJ; Harper JW; Niemann MA; Volanakis JE; Powers JC
J Biol Chem; 1987 Mar; 262(8):3444-51. PubMed ID: 3546307
[TBL] [Abstract][Full Text] [Related]
4. Structural biology of the alternative pathway convertase.
Xu Y; Narayana SV; Volanakis JE
Immunol Rev; 2001 Apr; 180():123-35. PubMed ID: 11414354
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the primary substrate specificity pocket of complement factor B. Asp(226) is a major structural determinant for p(1)-Arg binding.
Xu Y; Circolo A; Jing H; Wang Y; Narayana SV; Volanakis JE
J Biol Chem; 2000 Jan; 275(1):378-85. PubMed ID: 10617628
[TBL] [Abstract][Full Text] [Related]
6. Access to the complement factor B scissile bond is facilitated by association of factor B with C3b protein.
Hourcade DE; Mitchell LM
J Biol Chem; 2011 Oct; 286(41):35725-35732. PubMed ID: 21862585
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the type A domain of complement factor B that promote high-affinity C3b-binding.
Hourcade DE; Mitchell LM; Oglesby TJ
J Immunol; 1999 Mar; 162(5):2906-11. PubMed ID: 10072540
[TBL] [Abstract][Full Text] [Related]
8. Surface loops adjacent to the cation-binding site of the complement factor B von Willebrand factor type A module determine C3b binding specificity.
Tuckwell DS; Xu Y; Newham P; Humphries MJ; Volanakis JE
Biochemistry; 1997 Jun; 36(22):6605-13. PubMed ID: 9184140
[TBL] [Abstract][Full Text] [Related]
9. New structural motifs on the chymotrypsin fold and their potential roles in complement factor B.
Jing H; Xu Y; Carson M; Moore D; Macon KJ; Volanakis JE; Narayana SV
EMBO J; 2000 Jan; 19(2):164-73. PubMed ID: 10637221
[TBL] [Abstract][Full Text] [Related]
10. Structures of C3b in complex with factors B and D give insight into complement convertase formation.
Forneris F; Ricklin D; Wu J; Tzekou A; Wallace RS; Lambris JD; Gros P
Science; 2010 Dec; 330(6012):1816-20. PubMed ID: 21205667
[TBL] [Abstract][Full Text] [Related]
11. Structure and activation of complement components C2 and factor B.
Gagnon J
Philos Trans R Soc Lond B Biol Sci; 1984 Sep; 306(1129):301-9. PubMed ID: 6149575
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the A domain from complement factor B reveals an integrin-like open conformation.
Bhattacharya AA; Lupher ML; Staunton DE; Liddington RC
Structure; 2004 Mar; 12(3):371-8. PubMed ID: 15016353
[TBL] [Abstract][Full Text] [Related]
13. The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.
Krishnan V; Xu Y; Macon K; Volanakis JE; Narayana SV
Acta Crystallogr D Biol Crystallogr; 2009 Mar; 65(Pt 3):266-74. PubMed ID: 19237749
[TBL] [Abstract][Full Text] [Related]
14. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
[TBL] [Abstract][Full Text] [Related]
15. Production and functional activity of a recombinant von Willebrand factor-A domain from human complement factor B.
Williams SC; Hinshelwood J; Perkins SJ; Sim RB
Biochem J; 1999 Sep; 342 Pt 3(Pt 3):625-32. PubMed ID: 10477273
[TBL] [Abstract][Full Text] [Related]
16. Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
Hew BE; Wehrhahn D; Fritzinger DC; Vogel CW
Toxicon; 2012 Sep; 60(4):632-47. PubMed ID: 22609532
[TBL] [Abstract][Full Text] [Related]
17. The role of properdin in the assembly of the alternative pathway C3 convertases of complement.
Hourcade DE
J Biol Chem; 2006 Jan; 281(4):2128-32. PubMed ID: 16301317
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the short consensus repeats of human complement factor B by site-directed mutagenesis.
Hourcade DE; Wagner LM; Oglesby TJ
J Biol Chem; 1995 Aug; 270(34):19716-22. PubMed ID: 7649982
[TBL] [Abstract][Full Text] [Related]
19. Induced fit activation mechanism of the exceptionally specific serine protease, complement factor D.
Taylor FR; Bixler SA; Budman JI; Wen D; Karpusas M; Ryan ST; Jaworski GJ; Safari-Fard A; Pollard S; Whitty A
Biochemistry; 1999 Mar; 38(9):2849-59. PubMed ID: 10052957
[TBL] [Abstract][Full Text] [Related]
20. Conformational changes during the assembly of factor B from its domains by (1)H NMR spectroscopy and molecular modelling: their relevance to the regulation of factor B activity.
Hinshelwood J; Perkins SJ
J Mol Biol; 2000 Sep; 301(5):1267-85. PubMed ID: 10966820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
